Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
GENEREX BIOTECHNOLOGY CORP (GNBT)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Apr-30-21 | Jan-31-21 | Oct-31-20 | Jul-31-20 | Apr-30-20 | Jan-31-20 | Oct-31-19 | Jul-31-19 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues | | | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | | | | -40.6% | 7647580.0% | 108839.8% | 129998.0% | 32.8% |
| Gross profit | | | | 140.6% | -7647480.0% | -108739.8% | -129898.0% | 67.2% |
| Selling, general and administrative | | | | 133.6% | 79134760.0% | 826782.2% | 1176273.0% | 40.6% |
| Research and development | | | | 79.2% | | | | 28.2% |
| General and administrative | | | | 672.8% | | | | 345.3% |
| Depreciation | | | | 8.4% | 4037320.0% | 32105.2% | 44971.9% | -2.0% |
| EBIT | | | | -109.8% | -79134660.0% | -826682.2% | -1176173.0% | -92.7% |
| Pre-tax income | | | | -1286.8% | 0.0% | 0.0% | 0.0% | -177.5% |
| Income taxes | | | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | | | | -1253.1% | 0.0% | 0.0% | 0.0% | -150.7% |
|